Annual Drug Patent Expirations for VYXEOS
Vyxeos is a drug marketed by Celator Pharms and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
Drug patent litigation for VYXEOS.
This drug has one hundred and twenty-five patent family members in twenty-five countries.
The generic ingredient in VYXEOS is cytarabine; daunorubicin. One supplier is listed for this compound. Additional details are available on the cytarabine; daunorubicin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
You must log in to post a comment.